 | • レポートコード：MRC2304F056 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、250ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：バイオ |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の本市場調査資料では、世界のレポーター遺伝子アッセイ市場規模が、2021年に1,782.43百万ドル、2022年に2,104.87百万ドルになり、その後CAGR 18.34％で成長して2027年までに4,896.78百万ドルに達すると予測しています。本書は、レポーター遺伝子アッセイの世界市場を対象とした調査・分析結果をまとめたものであり、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品別分析（アッセイキット、試薬）、用途別分析（細胞シグナル伝達経路、遺伝子調節、プロモーター構造＆機能解析、タンパク質相互作用）、エンドユーザー別分析（学術＆研究機関、受託研究機関、病院＆診断検査室、製薬＆バイオテクノロジー企業）、地域別分析（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）、競争状況、企業情報などの内容を掲載しています。なお、本書内の企業情報には、Abcam PLC、Active Motif Inc.、Becton, Dickinson and Company、Berthold Technologies GmbH & Co.KG、Bio-Rad Laboratories、BioDetection Systems B.V.、Biotium Inc.、Cayman Chemical Company, Inc.、Genecopoeia, Inc.、INDIGO Biosciences, Inc.などが含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界のレポーター遺伝子アッセイ市場規模：製品別 - アッセイキットの市場規模 - 試薬の市場規模 ・世界のレポーター遺伝子アッセイ市場規模：用途別 - 細胞シグナル伝達経路における市場規模 - 遺伝子調節における市場規模 - プロモーター構造＆機能解析における市場規模 - タンパク質相互作用における市場規模 ・世界のレポーター遺伝子アッセイ市場規模：エンドユーザー別 - 学術＆研究機関における市場規模 - 受託研究機関における市場規模 - 病院＆診断検査室における市場規模 - 製薬＆バイオテクノロジー企業における市場規模 ・世界のレポーター遺伝子アッセイ市場規模：地域別 - 南北アメリカのレポーター遺伝子アッセイ市場規模 アメリカのレポーター遺伝子アッセイ市場規模 カナダのレポーター遺伝子アッセイ市場規模 ブラジルのレポーター遺伝子アッセイ市場規模 ... - アジア太平洋のレポーター遺伝子アッセイ市場規模 日本のレポーター遺伝子アッセイ市場規模 中国のレポーター遺伝子アッセイ市場規模 インドのレポーター遺伝子アッセイ市場規模 韓国のレポーター遺伝子アッセイ市場規模 台湾のレポーター遺伝子アッセイ市場規模 ... - ヨーロッパ/中東/アフリカのレポーター遺伝子アッセイ市場規模 イギリスのレポーター遺伝子アッセイ市場規模 ドイツのレポーター遺伝子アッセイ市場規模 フランスのレポーター遺伝子アッセイ市場規模 ロシアのレポーター遺伝子アッセイ市場規模 ... - その他地域のレポーター遺伝子アッセイ市場規模 ・競争状況 ・企業情報 |
The Global Reporter Gene Assay Market size was estimated at USD 1,782.43 million in 2021 and expected to reach USD 2,104.87 million in 2022, and is projected to grow at a CAGR 18.34% to reach USD 4,896.78 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Reporter Gene Assay to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product, the market was studied across Assay Kits and Reagents. The Assay Kits is further studied across Beta-galactosidase Assay Kits, Beta-glucuronidase Assay Kits, Chloramphenicol Acetyltransferase Assay Kits, Fluorescent Protein-related Assay Kits, Luciferase Assay Kits, and Secreted Embryonic Alkaline Phosphatase Assay Kits.
Based on Application, the market was studied across Cell Signaling Pathways, Gene Regulation, Promoter Structural and Functional Analysis, and Protein Interaction.
Based on End User, the market was studied across Academic & Research Institutes, Contract Research Organizations, Hospital & Diagnostic Laboratories, and Pharmaceutical & Biotechnology Companies.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Reporter Gene Assay market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Reporter Gene Assay Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Reporter Gene Assay Market, including Abcam PLC, Active Motif Inc., Becton, Dickinson and Company, Berthold Technologies GmbH & Co.KG, Bio-Rad Laboratories, BioDetection Systems B.V., Biotium Inc., Cayman Chemical Company, Inc., Genecopoeia, Inc., INDIGO Biosciences, Inc., InvivoGen, Merck KGaA, Molecular Devices, LLC, PerkinElmer, Inc., Promega Corporation, PromoCell GmbH, Takara Bio USA Holdings, Inc., Texcell SA, Thermo Fisher Scientific, Inc., and TopoGEN, Inc..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Reporter Gene Assay Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Reporter Gene Assay Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Reporter Gene Assay Market?
4. What is the competitive strategic window for opportunities in the Global Reporter Gene Assay Market?
5. What are the technology trends and regulatory frameworks in the Global Reporter Gene Assay Market?
6. What is the market share of the leading vendors in the Global Reporter Gene Assay Market?
7. What modes and strategic moves are considered suitable for entering the Global Reporter Gene Assay Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing use of gene expression
5.1.1.2. Advancements in the field of molecular biology
5.1.1.3. Demand for selectable markers in gene therapy research
5.1.1.4. Increasing demand for cell based assay
5.1.2. Restraints
5.1.2.1. Highly substrate dependent and low permeability
5.1.3. Opportunities
5.1.3.1. Preferences for using reporter gene assay in DNA construct in recent time
5.1.3.2. Rising demand for personalized medicine
5.1.4. Challenges
5.1.4.1. Limitation to provide only a 2-dimensional view of expression patterns
5.2. Cumulative Impact of COVID-19
6. Reporter Gene Assay Market, by Product
6.1. Introduction
6.2. Assay Kits
6.3.1. Beta-galactosidase Assay Kits
6.3.2. Beta-glucuronidase Assay Kits
6.3.3. Chloramphenicol Acetyltransferase Assay Kits
6.3.4. Fluorescent Protein-related Assay Kits
6.3.5. Luciferase Assay Kits
6.3.6. Secreted Embryonic Alkaline Phosphatase Assay Kits
6.3. Reagents
7. Reporter Gene Assay Market, by Application
7.1. Introduction
7.2. Cell Signaling Pathways
7.3. Gene Regulation
7.4. Promoter Structural and Functional Analysis
7.5. Protein Interaction
8. Reporter Gene Assay Market, by End User
8.1. Introduction
8.2. Academic & Research Institutes
8.3. Contract Research Organizations
8.4. Hospital & Diagnostic Laboratories
8.5. Pharmaceutical & Biotechnology Companies
9. Americas Reporter Gene Assay Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Reporter Gene Assay Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Reporter Gene Assay Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Abcam PLC
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. Active Motif Inc.
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. Becton, Dickinson and Company
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Berthold Technologies GmbH & Co.KG
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. Bio-Rad Laboratories
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. BioDetection Systems B.V.
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. Biotium Inc.
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. Cayman Chemical Company, Inc.
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. Genecopoeia, Inc.
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. INDIGO Biosciences, Inc.
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. InvivoGen
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. Merck KGaA
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. Molecular Devices, LLC
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. PerkinElmer, Inc.
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. Promega Corporation
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services
13.16. PromoCell GmbH
13.16.1. Business Overview
13.16.2. Key Executives
13.16.3. Product & Services
13.17. Takara Bio USA Holdings, Inc.
13.17.1. Business Overview
13.17.2. Key Executives
13.17.3. Product & Services
13.18. Texcell SA
13.18.1. Business Overview
13.18.2. Key Executives
13.18.3. Product & Services
13.19. Thermo Fisher Scientific, Inc.
13.19.1. Business Overview
13.19.2. Key Executives
13.19.3. Product & Services
13.20. TopoGEN, Inc.
13.20.1. Business Overview
13.20.2. Key Executives
13.20.3. Product & Services
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing